AngioDynamics Inc - ESG Rating & Company Profile powered by AI
This ESG rating includes 17 UN SDGs including: 'Good Health & Wellbeing', 'Responsible Production & Consumption' and 'Peace, Justice & Strong Institutions'. Jump to the bottom of the page for potential risks for AngioDynamics Inc based on industry, location and marketcap. The assessment of AngioDynamics Inc uses data points from across the internet and also from public filings by AngioDynamics Inc.
AngioDynamics Inc in the Medical Equipment, Supplies & Distribution industry gained a UN SDG ESG Transparency Score of 4.2; made up of an environmental score of 3.2, social score of 1.3 and governance score of 8.0.
4.2
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Bioteque Corp | 8.0 | High |
1 | Amplitude Surgical SA | 8.0 | High |
194 | Nippon Care Supply Co Ltd | 4.3 | High |
194 | Sri Trang Gloves (Thailand) PCL | 4.3 | High |
198 | AngioDynamics Inc | 4.2 | High |
198 | Hoshi Iryo-Sanki Co Ltd | 4.2 | High |
198 | ICU Medical Inc | 4.2 | High |
... | ... | ... | |
380 | ZoomMed Inc | 0.0 | Low |
380 | iRay Technology Co Ltd | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does AngioDynamics Inc have an accelerator or VC vehicle to help deliver innovation?
Does AngioDynamics Inc disclose current and historical energy intensity?
Does AngioDynamics Inc report the average age of the workforce?
Does AngioDynamics Inc reference operational or capital allocation in relation to climate change?
Does AngioDynamics Inc disclose its ethnicity pay gap?
Does AngioDynamics Inc disclose cybersecurity risks?
Does AngioDynamics Inc offer flexible work?
Does AngioDynamics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does AngioDynamics Inc disclose the number of employees in R&D functions?
Does AngioDynamics Inc conduct supply chain audits?
Does AngioDynamics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does AngioDynamics Inc conduct 360 degree staff reviews?
Does AngioDynamics Inc disclose the individual responsible for D&I?
Does AngioDynamics Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does AngioDynamics Inc disclose current and / or historical scope 2 emissions?
Does AngioDynamics Inc disclose water use targets?
Does AngioDynamics Inc have careers partnerships with academic institutions?
Did AngioDynamics Inc have a product recall in the last two years?
Does AngioDynamics Inc disclose incidents of discrimination?
Does AngioDynamics Inc allow for Work Councils/Collective Agreements to be formed?
Has AngioDynamics Inc issued a profit warning in the past 24 months?
Does AngioDynamics Inc disclose parental leave metrics?
Does AngioDynamics Inc disclose climate scenario or pathway analysis?
Does AngioDynamics Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does AngioDynamics Inc disclose the pay ratio of women to men?
Does AngioDynamics Inc support suppliers with sustainability related research and development?
Does AngioDynamics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does AngioDynamics Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is AngioDynamics Inc involved in embryonic stem cell research?
Does AngioDynamics Inc disclose GHG and Air Emissions intensity?
Does AngioDynamics Inc disclose its waste policy?
Does AngioDynamics Inc report according to TCFD requirements?
Does AngioDynamics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does AngioDynamics Inc disclose energy use targets?
Does AngioDynamics Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does AngioDynamics Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for AngioDynamics Inc
These potential risks are based on the size, segment and geographies of the company.
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides endovascular therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies that are used primarily to deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.